| Literature DB >> 28855800 |
Lisa Dybvik1, Erlend Skraastad2,3, Aigerim Yeltayeva4,5, Aidos Konkayev4,5, Tatiana Musaeva6, Igor Zabolotskikh6, Lars Bjertnaes7, Vegard Dahl1,8, Johan Raeder8, Vladimir Kuklin1.
Abstract
BACKGROUND: We recently introduced the efficacy safety score (ESS) as a new "call-out algorithm" for management of postoperative pain and side effects. In this study, we report the influence of ESS recorded hourly during the first 8 hours after surgery on the mobility degree, postoperative nonsurgical complications, and length of hospital stay (LOS).Entities:
Mesh:
Year: 2017 PMID: 28855800 PMCID: PMC5569639 DOI: 10.1155/2017/9431984
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Description of efficacy safety score (ESS).
| Score | |
|---|---|
|
| |
| Awake and alert patient | 0 |
| Awake patient but influenced by drugs; difficulties in communication | 5 |
| Acutely confused, upset/uneasy, hallucinated, or euphoric patient | 10 |
| Unresponsive patient | 15 |
|
| |
|
| |
| No postoperative nausea and vomiting | 0 |
| Postoperative nausea only | 5 |
| Postoperative nausea and vomiting/retching | 10 |
|
| |
|
| |
| No postoperative pain | 0 |
| Low-intensity postoperative pain (VNRS 1–3) | 1–3 |
| Moderate-intensity postoperative pain (VNRS 4–6) | 4–6 |
| Severe-intensity postoperative pain (VNRS 7–10) | 7–10 |
|
| |
|
| |
| No postoperative pain | 0 |
| Low-intensity postoperative pain (VNRS 1–3) | 1–3 |
| Moderate-intensity postoperative pain (VNRS 4–6) | 4–6 |
| Severe-intensity postoperative pain (VNRS 7–10) | 7–10 |
|
| |
|
| |
| Patient is stating feeling well | 0 |
| Patient has side effects apart from pain and nausea vomiting (e.g., sensation of warmth, flushing, itching, constipation, and urine retention) | 5 |
| Patient has acute severe circulation abnormalities (blood pressure ≤ 80 or ≥200 mmHg or mean arterial pressure < 50 mmHg and heart rate ≤ 40 or >110) | 15 |
| Patient has developed acute severe respiratory abnormalities (unusual respiration or respiration rate < 9 or >20/min, long pauses in breathing, and shallow breathing) | 15 |
Any single score of 15 (on either consciousness, circulation, or respiration) should call for immediate activation of acute assistance with the patient.
Figure 1Flow chart of the study.
Demographics, anthropometrics, and clinical characteristics of patients (n = 679) included in the study at the University Hospital of Astana.
| ESS ( | VNRS ( | Control ( |
| |
|---|---|---|---|---|
| Age: mean ± SD | 43.4 ± 16.4 | 42.4 ± 16.4 | 44.9 ± 15.8 |
|
| BMI: mean ± SD | 26.8 ± 6.1 | 26.3 ± 5.6 | 27 ± 5.9 |
|
| Gender | ||||
| Male: | 116 (50.8%) | 132 (58.1%) | 120 (53.6%) |
|
| Female: | 112 (49.2%) | 95 (41.9%) | 104 (46.4%) | |
| ASA classification: | ||||
| ASA I | 5 (2.2%) | 6 (2.6%) | 5 (2.2%) |
|
| ASA II | 145 (63.6%) | 131 (57.7%) | 126 (56.2%) | |
| ASA III | 76 (33.3%) | 89 (39.2%) | 96 (42.9%) | |
| ASA IV | 2 (0.9%) | 1 (0.4%) | 0 | |
| Type of surgery: | ||||
| Orthopedic | 202 (88.6%) | 199 (87.6%) | 207 (92.4%) |
|
| Abdominal | 10 (4.3%) | 14 (6.2%) | 9 (4%) | |
| Vascular | 16 (7%) | 14 (6.2%) | 8 (3.6%) | |
| Type of anaesthesia: | ||||
| Sevo + fentanyl | 74 (32.4%) | 81 (35.7%) | 79 (35.2%) |
|
| Regional | 38 (16.6%) | 46 (20.2%) | 45 (20%) | |
| SA ± EDA | 102 (44.7%)/4 (1.7%) | 93 (41%)/4 (1.8%) | 89 (39.7%)/6 (2.6%) | |
| TIVA | 14 (6.1%) | 9 (3.9%) | 8 (3.6%) | |
ANOVA; Chi square analysis. Sevo: sevoflurane; EDA: epidural anaesthesia; SA: spinal anaesthesia; TIVA: total intravenous anaesthesia.
Demographics, anthropometrics, and clinical characteristics of patients (n = 473) included in the study at the University Hospital of Krasnodar.
| Variables | ESS ( | VNRS ( | Control ( |
|
|---|---|---|---|---|
| Age: mean ± SD | 55.2 ± 14.7 | 55.1 ± 15.6 | 56 ± 14.9 |
|
| BMI: mean ± SD | 28 ± 17 | 27.8 ± 5.9 | 25.1 ± 4.5 |
|
| Gender | ||||
| Male: | 69 (38.2%) | 69 (36.4%) | 49 (48%) |
|
| Female: | 112 (61.8%) | 121 (63.6%) | 53 (51.9%) | |
| ASA classification: | ||||
| ASA I | 8 (4.4%) | 11 (5.7%) | 26 (25.5%) |
|
| ASA II | 99 (54.6%) | 100 (52.6%) | 53 (51.9%) | |
| ASA III | 72 (39.7%) | 78 (41%) | 22 (21.6%) | |
| ASA IV | 2 (1.1%) | 2 (1%) | 1 (0.9%) | |
| Type of surgery: | ||||
| Abdominal | 115 (63.5%) | 125 (65.7%) | 61 (59.8%) |
|
| Endocrine | 29 (16%) | 18 (9.4%) | 5 (4.9%) | |
| Gynaecology | 19 (10.4%) | 9 (4.7%) | 12 (11.7%) | |
| Urology | 13 (7.1%) | 18 (9.4%) | 16 (15.6%) | |
| Vascular | 5 (2.7%) | 20 (10.5%) | 8 (7.8%) | |
| Type of anaesthesia: | ||||
| Sevo + fentanyl | 100 (55.2%) | 103 (54.2%) | 38 (37.2%) |
|
| Sevo + fentanyl + EDA | 77 (42.5%) | 68 (35.7%) | 45 (44.1%) | |
| SA ± EDA | 7 (3.8%)/6 (3.3%) | 15 (7.8%)/7 (3.6%) | 14 (13.7%)/4 (3.9%) | |
| TIVA | 3 (1.6%) | 2 (1%) | 5 (4.9%) | |
ANOVA; Chi square analysis. Sevo: sevoflurane; EDA: epidural anaesthesia; SA: spinal anaesthesia.; TIVA: total intravenous anaesthesia.
Figure 2Length of hospital stay (LOS) of patients included in the study in University Hospital of Astana, Astana, Kazakhstan (n = 679). Data are presented as vertical boxes with median (solid line), mean (dashed line), and interquartile range with 10th percentile and 90th percentile error bars. Outliers are presented as open circles. P = 0.011 comparing ESS group versus Control group.
Figure 3Length of hospital stay (LOS) of patients included in the study in University Hospital of Krasnodar, Krasnodar, Russia (n = 473). Data are presented as vertical boxes with median (solid line), mean (dashed line), and interquartile range with 10th percentile and 90th percentile error bars. In the VNRS group, the 10th percentile error bar is matching with the lower line of the box. Outliers are presented as open circles. P = 0.022 comparing ESS group versus Control group.
Figure 4Length of hospital stay (LOS) of patients included in the study from both hospitals (n = 1152). Data are presented as vertical boxes with median (solid line), mean (dashed line), and interquartile range with 10th percentile and 90th percentile error bars. Outliers are presented as open circles. P < 0.001 comparing ESS group versus Control group.
Pooled demographics, anthropometrics, and clinical characteristics of patients included in the study after laparoscopic cholecystectomy from the university hospitals of Astana and Krasnodar (n = 114).
| ESS group | VNRS group | Control group |
| |
|---|---|---|---|---|
| Age: mean ± SD | 51.8 ± 14.9 | 49.7 ± 13.4 | 56 ± 12.5 |
|
| BMI: mean ± SD | 26.8 ± 4.2 | 29.2 ± 5.8 | 27.1 ± 4.5 |
|
| Gender | ||||
| Male: | 10 (27.7%) | 11 (20.4%) | 5 (20.8%) |
|
| Female: | 26 (72.3%) | 43 (79.6%) | 19 (79.2%) | |
| ASA classification: | ||||
| ASA I | 1 (2.7%) | 4 (7.4%) | 3 (12.5%) |
|
| ASA II | 23 (63.8%) | 34 (62.9%) | 11 (45.8%) | |
| ASA III | 12 (33.3%) | 16 (29.6%) | 10 (41.6%) | |
| Type of anaesthesia: | ||||
| Sevo + Fentanyl | 36 (100%) | 47 (100%) | 15 (100%) | |
ANOVA; Chi square analysis. Sevo: sevoflurane.
Figure 5Length of hospital stay (LOS) of patients included in the study after laparoscopic cholecystectomy from both hospitals (n = 114). Data are presented as vertical boxes with mean (dashed line) and interquartile range with 10th percentile and 90th percentile error bars. In the ESS and VNRS groups, the 10th percentile error bar is matching with the lower lines of the boxes. Outliers are presented as open circles. #ESS group versus Control group, P = 0.003; #ESS group versus VNRS group, P < 0.001.